AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported first quarter 2025 results in a May 13th press ...

A class of older drugs used to treat type 2 diabetes may also help slow the progression of prostate cancer, a small study ...

Market OverviewBreast cancer remains one of the most prevalent forms of cancer worldwide, affecting millions of individuals ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

A group led by researchers at the A.C.Camargo Cancer Center has succeeded in improving CAR-T cells, making them more ...

Melanoma care varies by stage, with early cases being treated with surgery, whereas advanced disease often requires ...

Immune checkpoint inhibitors have revolutionized cancer therapy by reversing tumor-induced immunosuppression, but they fail to work for many patients because of resistance. In addition, they can ...

Science and society collaboration is essential for scientific progress, especially in the health and biomedical fields where basic researchers, clinicians and patients are involved, as shown by the ...

Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...

Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced ...